Cargando…

T‐cell response to phytohemagglutinin in the interferon‐γ release assay as a potential biomarker for the response to immune checkpoint inhibitors in patients with non‐small cell lung cancer

BACKGROUND: Immune checkpoint inhibitors are a standard treatment for advanced lung cancer, although it remains important to identify biomarkers that can accurately predict treatment response. Immune checkpoint inhibitors enhance the antitumor T‐cell response, and interferon‐γ plays an important rol...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kamimaki, Chisato, Kobayashi, Nobuaki, Hirata, Momo, Somekawa, Kohei, Fukuda, Nobuhiko, Kubo, Sousuke, Katakura, Seigo, Teranishi, Shuhei, Watanabe, Keisuke, Horita, Nobuyuki, Hara, Yu, Yamamoto, Masaki, Kudo, Makoto, Piao, Hongmei, Kaneko, Takeshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons Australia, Ltd 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8169292/ https://www.ncbi.nlm.nih.gov/pubmed/33943031 http://dx.doi.org/10.1111/1759-7714.13978

Ejemplares similares

Resistance mechanisms of epidermal growth factor receptor tyrosine kinase inhibitors in non‐small cell lung cancer patients: A meta‐analysis
por: Kobayashi, Nobuaki, et al.
Publicado: (2021)

Class A CpG oligodeoxynucleotide inhibits IFN‐γ‐induced signaling and apoptosis in lung cancer
por: Teranishi, Shuhei, et al.
Publicado: (2020)

MicroRNA‐200b is a potential biomarker of the expression of PD‐L1 in patients with lung cancer
por: Katakura, Seigo, et al.
Publicado: (2020)

Pembrolizumab monotherapy versus pembrolizumab plus chemotherapy in patients with non‐small‐cell lung cancer: A multicenter retrospective trial
por: Matsumoto, Hiromi, et al.
Publicado: (2021)

Afatinib + bevacizumab combination therapy in EGFR‐mutant NSCLC patients with osimertinib resistance: Protocol of an open‐label, phase II, multicenter, single‐arm trial
por: Kobayashi, Nobuaki, et al.
Publicado: (2020)

Regional differences in epidermal growth factor receptor-tyrosine kinase inhibitor therapy in lung cancer treatment using a national database in Japan
por: Matsumoto, Hiromi, et al.
Publicado: (2023)

The best regimens for chemo-naïve incurable non-squamous non-small cell lung cancer with a programmed death-ligand 1, tumor proportion score 1–49%: a network meta-analysis
por: Fukuda, Nobuhiko, et al.
Publicado: (2021)

Non‐small cell lung cancer with mesenchymal–epithelial transition gene exon 14 skipping mutation treated with crizotinib
por: Katakura, Seigo, et al.
Publicado: (2019)

Adverse events induced by durvalumab and tremelimumab combination regimens: a systematic review and meta-analysis
por: Matsumoto, Hiromi, et al.
Publicado: (2023)

Best regimens for treating chemo‐naïve incurable squamous non‐small cell lung cancer with a programmed death‐ligand 1 tumor proportion score of 1%–49%: A network meta‐analysis
por: Fukuda, Nobuhiko, et al.
Publicado: (2021)

Adverse events induced by nivolumab and ipilimumab combination regimens
por: Somekawa, Kohei, et al.
Publicado: (2022)

Tailoring Therapeutic Strategies in Non-Small-Cell Lung Cancer: The Role of Genetic Mutations and Programmed Death Ligand-1 Expression in Survival Outcomes
por: Kobayashi, Nobuaki, et al.
Publicado: (2023)

Early swelling response to phytohemagglutinin is lower in older toads
por: Zamora-Camacho, Francisco Javier, et al.
Publicado: (2018)

Immunohistochemical markers to diagnose primary squamous cell carcinoma of the lung: a meta-analysis of diagnostic test accuracy
por: Chen, Hao, et al.
Publicado: (2022)

Computed tomography imaging‐based observation of the aggressive growth of angiosarcoma: a case study
por: Kubo, Sousuke, et al.
Publicado: (2019)

Synergistic and suppressive interactions among mouse T lymphocytes in the response to phytohemagglutinin
Publicado: (1975)

A functionally improved case of obstructive impairment caused by systemic lupus erythematosus
por: Kamimaki, Chisato, et al.
Publicado: (2021)

Low interferon-gamma release in response to phytohemagglutinin predicts the high severity of diseases
por: He, Xing, et al.
Publicado: (2019)

Immune responsiveness to phytohemagglutinin displays species but not sex differences in three anuran species
por: Zhang, Zhiqiang, et al.
Publicado: (2017)

Primary tracheal small‐cell carcinoma detected 11 months after surgery for pulmonary large‐cell neuroendocrine carcinoma: A case report
por: Sugimoto, Chihiro, et al.
Publicado: (2023)

Thymic atypical carcinoid tumors with elevated mitotic counts in a patient with multiple endocrine neoplasia: A case report
por: Hiro, Shuntaro, et al.
Publicado: (2023)

Predictors of lung injury during durvalumab maintenance therapy following concurrent chemoradiotherapy in unresectable locally advanced non‐small cell lung carcinoma
por: Hirama, Nobuyuki, et al.
Publicado: (2023)

Cytokinetic analysis of the impaired proliferative response of peripheral lymphocytes from aged humans to phytohemagglutinin
Publicado: (1979)

Liquid biopsy for detecting epidermal growth factor receptor mutation among patients with non-small cell lung cancer treated with afatinib: a multicenter prospective study
por: Fujii, Hiroaki, et al.
Publicado: (2022)

Clinical Features and Risk Factors for Mortality in Hospitalized Older Adults with Pneumonia
por: Fukuda, Nobuhiko, et al.
Publicado: (2021)

THE EFFECTS OF ANTIGENS AND OF PHYTOHEMAGGLUTININ ON RABBIT SPLEEN CELL SUSPENSIONS
por: Harris, G., et al.
Publicado: (1966)

Characterization of DNA excreted from phytohemagglutinin-stimulated lymphocytes
Publicado: (1976)

THE EFFECTS OF THROMBIN ON PHYTOHEMAGGLUTININ RECEPTOR SITES IN HUMAN PLATELETS
por: Feagler, John R., et al.
Publicado: (1974)

Differential sister chromatid exchange response in phytohemagglutinin and pokeweed stimulated lymphocytes of goat (Capra hircus L)
por: Di Berardino, D, et al.
Publicado: (1997)

CELLS INVOLVED IN THE IMMUNE RESPONSE : XVI. THE RESPONSE OF IMMUNE RABBIT CELLS TO PHYTOHEMAGGLUTININ, ANTIGEN, AND GOAT ANTI-RABBIT IMMUNOGLOBULIN ANTISERUM
por: Daguillard, Fritz, et al.
Publicado: (1970)

The Effectiveness and Safety of Long-Term Macrolide Therapy for COPD in Stable Status: A Systematic Review and Meta-Analysis
por: Nakamura, Kazunori, et al.
Publicado: (2023)

Diagnostic utility of transbronchial biopsy for Hodgkin's lymphoma: A case study
por: Hoshi, Miki, et al.
Publicado: (2021)

SPECIFIC INHIBITION BY RIFAMPICIN OF TRANSCRIPTION IN HUMAN LYMPHOCYTES STIMULATED BY PHYTOHEMAGGLUTININ
por: Pogo, Beatriz G. T.
Publicado: (1972)

The plant vacuolar protein, phytohemagglutinin, is transported to the vacuole of transgenic yeast
Publicado: (1987)

HEMOPOIETIC SPLEEN COLONY STUDIES : IV. PHYTOHEMAGGLUTININ AND HEMOPOIETIC REGENERATION
por: Curry, J. L., et al.
Publicado: (1967)

Phytohemagglutinin ameliorates HFD-induced obesity by increasing energy expenditure
por: Zhang, Yunxia, et al.
Publicado: (2021)

Histological assessment of cellular immune response to the phytohemagglutinin skin test in Brazilian free-tailed bats (Tadarida brasiliensis)
por: Turmelle, Amy S., et al.
Publicado: (2010)

Disease control and objective responsive rates in randomized phase II trials evaluating non-first-line chemotherapy for non-small cell lung cancer: a systematic review of 74 trials
por: Matsumoto, Hiromi, et al.
Publicado: (2021)

THE EFFECT OF PHYTOHEMAGGLUTININ ON RIBONUCLEIC ACID SYNTHESIS AND HISTONE ACETYLATION IN EQUINE LEUKOCYTES
por: Pogo, B. G. T., et al.
Publicado: (1967)

PHYTOHEMAGGLUTININ MITOGENIC PROTEINS : STRUCTURAL EVIDENCE FOR A FAMILY OF ISOMITOGENIC PROTEINS
por: Miller, J. Bruce, et al.
Publicado: (1973)

Cannot write session to /tmp/vufind_sessions/sess_alvh8u8om7t4ad5qo37scbfis5